close

Blogs > Patent Law Blog

IP Attorney

Feb 11, 2019

Developing IP Strategy for FDA-Regulated Drug Products Requires Special Considerations

Despite the widely diverging needs of the different industries that make use of the US patent system, US patent law applies essentially the same rules to innovations from all technology fields. This means that drug and biotechnology-based inventions are treated no differently by the U.S. » Read More

Jan 12, 2018

Kurt Briscoe Participates in Panel Discussion with The Knowledge Group

On January 26, I will be participating in a panel discussion with The Knowledge Group where I will cover the role of secondary considerations in formulation obviousness and the use of post-priority-date evidence to prove a patent lacks written description of a claimed genus. » Read More

Subscribe